To report tamoxifen ocular toxicity. The best visual acuity was measured in both eyes with Snellen chart, slit-lamp examination of anterior segment, refraction, dilated fundus examination, fluorescein angiography and retinography in a 63-year-old patient, female, white, using tamoxifen 20 mg/day for 4 years, with 20/70 and 20/40 corrected visual acuity. The anterior segment examination showed corneal linear subepithelial opacity inferior to the visual axis and nuclear and posterior cortical cataract (1+/4) in both eyes. Fundus examination showed alteration of macular color in both eyes. Fluorescein angiography presented hyperfluorescence in the macular area at an early phase (window defect). Report of keratopathy and maculopathy caused by tamoxifen.
Breast neoplasms; Tamoxifen; Tamoxifen; Drug toxicity; Macular degeneration; Fundus oculi; Macula lutea; Fluorescein angiography; Retinal diseases; Case report
